PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 27 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $6,000 | -57.1% | 1,189 | -77.7% | 0.01% | -50.0% |
Q1 2017 | $14,000 | +55.6% | 5,342 | -16.8% | 0.01% | +200.0% |
Q4 2016 | $9,000 | +125.0% | 6,424 | +167.7% | 0.00% | +33.3% |
Q2 2016 | $4,000 | +33.3% | 2,400 | +71.4% | 0.00% | +50.0% |
Q1 2016 | $3,000 | – | 1,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
CM Management, LLC | 649,400 | $193,521 | 0.20% |
BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |